• Users Online: 160
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login

Ahead of Print policy

Articles published online under the Ahead of Print model are considered published and can be cited and quoted using the DOI as the reference source. Wolters Kluwer Medknow has a policy that changes will not be made after publication of an article without following accepted procedures for making corrections to the scientific record.



 Coming soon

EDITORIAL
1.  Biologics in Psoriasis: Indian Experience.
LETTER TO EDITOR
1.  Drug induced Henoch Schonlein purpura with severe GI involvement
2.  Potassium Iodide : A prodigy in the Treatment of Subcutaneous zygomycosis
3.  Drug Induced Hypersensitivity Syndrome (DIHS) to Leflunomide.
4.  A first case of late onset Imatinib mesylate induced lichenoid drug eruption.
BRIEF REPORT
1.  News from Regulatory Corner: Safety Communication and Recent Drug Approvals
ORIGINAL ARTICLE
1.  Oral ranitidine: A promising novel therapeutic option in molluscum contagiosum in children
2.  Real-life efficacy and safety of secukinumab : Single centre, retrospective observational study with 52 weeks follow up
3.  A comparative study between topical adapalene (0.1%) vs combination of topical adapalene (0.1%) and intense pulsed light (ipl) therapy in treatment of inflammatorory and non inflammatory facial acne vulgaris: A split face randomized controlled trial
4.  Real world experience on the effectiveness and tolerability of Apremilast in patients with plaque psoriasis in India
5.  Assessment of Cutaneous Adverse Drug Reactions (CADRs) in a tertiary care hospital
CASE REPORT
1.  RARE TOXICITY WITH OXALIPLATIN – STEVEN JOHNSON SYNDROME
2.  Sorafenib induced cutaneous toxicities: Four different presentations
3.  Successful treatment of pyogenic granuloma with sclerotherapy
4.  Thalidomide Induced Leukocytoclastic Vasculitis In Leprosy
5.  ‘PRIDE’ COMPLEX: A Report of two cases
6.  Delayed onset serum sickness due to rituximab in pemphigus vulgaris –a case report
REVIEW ARTICLE
1.  SUNSCREENS
2.  Janus kinase inhibitors in Dermatology
3.  Managing a side effect- Cyclophosphamide induced hemorrhagic cystitis